Silverback Asset Management »

Eyepoint Pharmaceuticals shares owned by Silverback Asset Management

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Silverback Asset Management from 13F filings

Historical chart of Silverback Asset Management investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Silverback Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Silverback Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.9M 150k 12.89

More positions owned by Silverback Asset Management

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Indie Semiconductor Note 3.500 12815 (Principal)
On Semiconductor Corp Note 5/0 (Principal)
Vishay Intertechnology Note 2.250% 9/1 (Principal)
Uber Technologies Note 0.875%12/0 (Principal)
Semtech Corp Note 1.625%11/0 (Principal)
Bridgebio Pharma Note 2.250% 2/0 (Principal)
IAC FinanceCo 2 Note 0.875% 06/15 (Principal)
Nutanix Note 0.250%10/0 (Principal)
Oracle Corp 6.5 Dep Cum Sr D (Principal) (ORCL.PD)
Synaptics Note 0.750%12/0 (Principal)
Porch Group Debt 9.000% 5/1 (Principal)
Varonis Sys Note 1.000% 9/1 (Principal)
Porch Group Note 6.750% 10/1 (Principal)

View all positions for Silverback Asset Management

Top funds holding Eyepoint Pharmaceuticals

Suvretta Capital Management
Cormorant Asset Management
BlackRock
Federated Investors
Franklin Resources
Vanguard Group
Adage Capital Partners GP
Henderson Group
Vanguard Capital Management
Paradigm Biocapital Advisors
Commodore Capital
Citadel Advisors
Geode Capital Management
State Street Corporation
Standard Life Aberdeen

View all funds holding Eyepoint Pharmaceuticals